GENENCOR INTERNATIONAL INC
10-Q, EX-11, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENENCOR INTERNATIONAL INC, 10-Q, 2000-11-14
Next: GENENCOR INTERNATIONAL INC, 10-Q, EX-27, 2000-11-14



<PAGE>   1
                                                                      EXHIBIT 11


                  GENENCOR INTERNATIONAL, INC. AND SUBSIDIARIES

         UNAUDITED STATEMENT REGARDING COMPUTATION OF PER SHARE EARNINGS
             (AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)


<TABLE>
<CAPTION>

                                                             THREE MONTHS ENDED             NINE MONTHS ENDED
                                                                SEPTEMBER 30,                 SEPTEMBER 30,
                                                                -------------                 -------------
                                                             2000          1999           2000            1999
                                                             ----          ----           ----            ----
<S>                                                   <C>             <C>             <C>             <C>
Net income                                            $      4,753    $       (293)   $     25,984    $      7,335

Less: Accrued dividends on preferred stock
                                                            (1,819)         (1,819)         (5,457)         (5,457)
                                                      ------------    ------------    ------------    ------------

Net income available to holders of common             $      2,934    $     (2,112)   $     20,527    $      1,878
 stock (a)                                            ============    ============    ============    ============


Basic:
  Weighted average shares of common stock
  outstanding (b)                                       56,873,167      50,000,000      52,703,611      50,000,000
                                                      ============    ============    ============    ============
Basic earnings per common share [(a)/(b)]             $       0.05    $      (0.04)   $       0.39    $       0.04
                                                      ============    ============    ============    ============


Diluted:
  Weighted average shares of common stock
  outstanding (c)                                       59,501,875      50,000,000      54,964,499      50,000,000
                                                      ============    ============    ============    ============
Diluted earnings per common share [(a)/(c)]           $       0.05    $      (0.04)   $       0.37    $       0.04
                                                      ============    ============    ============    ============
</TABLE>



                                       21


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission